QID 379442

Date Published: 2024-03-05

QID 379442: MicroDicom DICOM Viewer Multiple Vulnerabilities

CVE-2024-22100: MicroDicom DICOM Viewer versions 2023.3 (Build 9342) and prior are affected by a heap-based buffer overflow vulnerability, which could allow an attacker to execute arbitrary code on affected installations of DICOM Viewer. A user must open a malicious DCM file in order to exploit the vulnerability.

CVE-2024-25578: MicroDicom DICOM Viewer versions 2023.3 (Build 9342) and prior contain a lack of proper validation of user-supplied data, which could result in memory corruption within the application.

Affected Versions:
MicroDicom DICOM Viewer versions prior to 2024.1

QID Detection Logic (Authenticated):
This QID checks for vulnerable version of MicroDicom DICOM Viewer by checking the fileversion of 'mDicom.exe'. Please note that this QID will only detect installations done via an Installer.

Successful exploitation of these vulnerabilities could allow an attacker to cause memory corruption issues leading to execution of arbitrary code.

CVSS V3 rated as High - 7.8 severity.

CVSS V2 rated as Medium - 4.6 severity.

Solution

Customers are advised to upgrade to MicroDicom DICOM Viewer 2024.1 or later. For more information regarding the vulnerability, please refer to the ICSMA-24-060-01

Vendor References

ICSMA-24-060-01 - www.cisa.gov/news-events/ics-medical-advisories/icsma-24-060-01

CVEs related to QID 379442

CVE-2024-22100 | CVE-2024-25578 |

Software Advisories

Advisory ID	Software	Component	Link
ICSMA-24-060-01			www.cisa.gov/news-events/ics-medical-advisories/icsma-24-060-01

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].